Better Choice CO INC 8-K filings

SRX Global Inc. filed an amendment to its Form 8-K to correct a typographical error regarding the Chief Executive Officer's identification, clarifying Carolina Martinez as Chief Financial Officer.

SRX Global Inc. announced the successful completion of an additional closing for its private placement, raising approximately $3.47 million in cash.

SRX Global Inc. announced a Limited Waiver and Consent Agreement with Required Holders, allowing for a one-time cash dividend and a significant stock repurchase plan.

SRX Global Inc. announced it has regained full compliance with all NYSE American continued listing standards, resolving deficiencies previously noted.

SRX Global Inc. announced paper-traded EMJX returns of 26% from February 11, 2026, to July 10, 2026, significantly outperforming Bitcoin's -4.2% return over the same period.

SRX Global schedules a virtual fireside chat for July 14, 2026, to discuss recent developments, including the EMJX acquisition, and announces a share repurchase program and a cash dividend.

SRX Global Inc. has published an updated investor presentation to its corporate website to provide stakeholders with current strategic insights.

SRX Global, Inc. will implement a 1-for-60 reverse stock split on July 6, 2026, to regain compliance with NYSE American listing standards.

SRx Health Solutions has finalized its acquisition of EMJ Crypto Technologies, rebranding as SRX Global Inc. and launching an AI-driven platform strategy focused on high-conviction operating companies and assets.

SRx Health Solutions, through its subsidiary Halo, Purely for Pets, has invested over 10% of its treasury assets in Astro Investment XVII, an affiliate of Astro Capital, focusing on AI and space convergence.

SRx Health Solutions and EMJ Crypto Technologies have filed a Form S-4 registration statement, marking a key milestone in their proposed merger.

SRx Health Solutions Inc. announced a private placement raising $4.528 million through the sale of Series B convertible preferred stock and warrants, with potential for up to $8 million.

SRx Health Solutions obtains waivers from existing investors to proceed with a new Series B convertible preferred stock offering, ranking pari passu with Series A.

SRx Health Solutions, Inc. announced that the NYSE American has accepted its plan to regain compliance with continued listing standards, granting an extension until July 14, 2026.

SRx Health Solutions' stockholders approved a name change to EMJX, an acquisition of AI crypto technology, and new board members, contingent on the transaction's closing.

SRx Health Solutions, Inc. announced a definitive agreement to acquire EMJ Crypto Technologies and related IP for approximately $55 million in an all-stock transaction, signaling a strategic pivot to a digital-asset treasury operating system led by EMJX's founder, Eric M. Jackson.

SRx Health Solutions, Inc. has increased its authorized common stock from 200 million to 5 billion shares, effective November 19, 2025, following stockholder approval.

SRx Health Solutions, Inc. announced the immediate appointment of Sammy Dorf, a seasoned executive from the cannabis and crypto sectors, to its Board of Directors.

SRx Health Solutions Inc. completed a $15.23 million private placement of preferred stock and warrants, while expanding its equity line of credit to $1 billion, even as it faces NYSE American delisting concerns.

SRx Health Solutions received a notice from NYSE American for non-compliance with continued listing standards due to insufficient stockholders' equity.

SRx Health Solutions' stockholders have approved significant measures including increasing authorized shares, facilitating future equity issuances, and authorizing another reverse stock split.

SRx Health Solutions, Inc. announced the immediate appointment of Joshua A. Epstein to its Board of Directors and Compensation Committee, effective October 1, 2025.

SRx Health Solutions, Inc. has appointed Davidson and Company LLP as its new independent auditor, replacing CBIZ CPAs P.C., following a series of internal control weaknesses and a revenue recognition error.

SRx Health Solutions, Inc. announced the cancellation of approximately 18.8 million shares of its Canadian subsidiary's capital stock and the resignation of a director amidst ongoing financial challenges.

SRx Health Solutions' Canadian subsidiary initiates restructuring proceedings under the Companies Creditors Arrangement Act (CCAA).

SRx Health Solutions, Inc. stockholders have approved a reverse stock split at a ratio between 15-to-1 and 60-to-1, granting the board discretion over its implementation.

SRx Health Solutions, Inc. announced a significant leadership transition with the appointment of Kent Cunningham as Chief Executive Officer, the elevation of former CEO Adesh Vora to Vice Chairman of the Board, and an amendment to CFO Carolina Martinez's employment agreement.

SRx Health Solutions Inc. has significantly bolstered its financial position by closing a $7.3 million senior secured convertible note financing and securing a $50 million equity line of credit, aiming to fuel U.S. acquisitions and expand its Canadian specialty pharma operations.

SRx Health Solutions, Inc. (formerly Better Choice Company, Inc.) has filed an amendment to its current report, revealing a reverse merger with SRx Health Solutions (Canada), Inc. and disclosing significant financial losses, a substantial accumulated deficit, and material uncertainties regarding its ability to continue as a going concern.

SRx Health Solutions, Inc. has announced significant changes to its executive leadership and Board of Directors, including new appointments for CEO, President, Chairman, and CFO, signaling a renewed strategic focus.